Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,515.14
(
-0.07%
)
US TECH 100
29,104.80
(
-0.25%
)
Dow Jones
50,446.32
(
-0.39%
)
Brent Oil
94.35
(
2.06%
)
Bitcoin
72,525.87
(
-3.15%
)
News Focus
News Focus
Post# of 57986
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

atheroprevent

Send PM Follow Ignore
Followers 2
Posts 674
Boards Moderated 0
Alias Born 08/01/2006

atheroprevent

Re: haysaw post# 32638

Monday, 03/15/2010 10:10:04 AM

Monday, March 15, 2010 10:10:04 AM

Post# of 57986
Of further interest, the Accord trial tarnished 2 Novartis drugs while Amln looks to move forward with the once weekly Byetta today. I am sorry you dropped your interest in Amln, Jerry. Byetta is one of the few diabetes drugs with associated with weight loss.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today